Sirion Holdings, Inc. Contracts & Agreements
47 Contracts & Agreements
- Business Finance (15 contracts)
- Business Operations (6)
- Human Resources (5)
- Intellectual Property (5)
- Mergers & Acquisitions (1)
- Real Estate (3)
- Uncategorized (12)
- EX-10.1 AMENDMENT TO INVESTORS' RIGHTS AGREEMENT (Filed With SEC on December 22, 2006)
- Ex-10.1 FORM OF INCENTIVE STOCK OPTION AGREEMENT (Filed With SEC on November 21, 2006)
- Ex-10.2 FORM OF NONQUALIFIED STOCK OPTION AGREEMENT (Filed With SEC on November 21, 2006)
- AGREEMENT AND PLAN OF MERGER AND REORGANIZATION (Filed With SEC on September 18, 2006)
- EXCLUSIVE LICENSE AGREEMENT (Filed With SEC on September 18, 2006)
- EXCLUSIVE LICENSE AGREEMENT (Filed With SEC on September 18, 2006)
- STOCK PURCHASE AGREEMENT (Filed With SEC on September 18, 2006)
- AGREEMENT FOR SALE AND PURCHASE OF MEMBERSHIP INTERESTS (Filed With SEC on September 18, 2006)
- MASTER SERVICE AGREEMENT (Filed With SEC on September 18, 2006)
- LICENSE AGREEMENT (Filed With SEC on September 18, 2006)
- MEMBERSHIP INTEREST PURCHASE AGREEMENT (Filed With SEC on September 18, 2006)
- CONTRIBUTION AGREEMENT (Filed With SEC on September 18, 2006)
- SERIES A PREFERRED STOCK PURCHASE AGREEMENT (Filed With SEC on September 18, 2006)
- INVESTORS RIGHTS AGREEMENT (Filed With SEC on September 18, 2006)
- LEASE ASSIGNMENT AND ASSUMPTION (Filed With SEC on September 18, 2006)
- ENCLOSED IS THE LEASE AGREEMENT (Filed With SEC on September 18, 2006)
- SUBLEASE AGREEMENT (Filed With SEC on September 18, 2006)
- TENBY PHARMA INC. (Filed With SEC on September 18, 2006)
- Date: April 25, 2006To: Dawn Bennet JohnsonFrom: Barry ButlerSubject: Offer letter (Filed With SEC on September 18, 2006)
- Date: April 25, 2006To: William StringerFrom: Barry ButlerSubject: Offer letter (Filed With SEC on September 18, 2006)
- CONSULTING AGREEMENT (Filed With SEC on September 18, 2006)
- CONSULTING AGREEMENT (Filed With SEC on September 18, 2006)
- CONSULTING AGREEMENT (Filed With SEC on September 18, 2006)
- FORM OF INDEMNIFICATION AGREEMENT (Filed With SEC on September 18, 2006)
- FORM OF NONCOMPETITION AND NONSOLICITATION AGREEMENT (Filed With SEC on September 18, 2006)
- RxDR BPI By: /s/ Barry Butler By: /s/ Barry Butler Barry Butler Partner/CEO Barry Butler, President By: /s/ Roger Vogel Roger Vogel, MD Partner/CMO (Filed With SEC on September 18, 2006)
- RxDR Rogellen Partners, Inc. By: /s/ Barry Butler By: /s/ Roger Vogel Barry Butler Partner/CEO Roger Vogel, MD, President By: /s/ Roger Vogel Roger Vogel, MD Partner/CMO (Filed With SEC on September 18, 2006)
- PROMISSORY NOTE $12,500.00 February 7, 2006 (Filed With SEC on September 18, 2006)
- PROMISSORY NOTE $5,000.00 June 15, 2006 (Filed With SEC on September 18, 2006)
- TERMINATION AND ACKNOWLEDGEMENT AGREEMENT (Filed With SEC on September 18, 2006)
- Confidential EXECUTION VERSION LOAN AGREEMENT (Filed With SEC on September 18, 2006)
- FIRST AMENDMENT TO LOAN AGREEMENT (Filed With SEC on September 18, 2006)
- Confidential EXECUTION VERSION SECURITY AGREEMENT (Filed With SEC on September 18, 2006)
- PROMISSORY NOTE $5,000,000 February 14, 2006 (Filed With SEC on September 18, 2006)
- Confidential EXECUTION VERSION SIRION THERAPEUTICS, INC. (Filed With SEC on September 18, 2006)
- TERMINATION OF LOAN DOCUMENTS AND INVESTORS RIGHTS AGREEMENT (Filed With SEC on September 18, 2006)
- MASTER LABORATORY SERVICES AGREEMENT (Filed With SEC on September 18, 2006)
- Appendix I-1 (Filed With SEC on September 18, 2006)
- EXCLUSIVE LICENSE AGREEMENT (Filed With SEC on September 18, 2006)
- EXCLUSIVE LICENSE AGREEMENT (Filed With SEC on September 18, 2006)
- SOFTGEL DEVELOPMENT AND CLINICAL SUPPLY AGREEMENT (Filed With SEC on September 18, 2006)
- QUOTATION (Filed With SEC on September 18, 2006)
- QUOTATION (Filed With SEC on September 18, 2006)
- QUOTATION (Filed With SEC on September 18, 2006)
- Re: Proposed Development and Supply Agreement between Sirion Therapeutics, Inc.(Sirion) and Plantex USA, Inc. (Plantex) for Diflurprednate (Filed With SEC on September 18, 2006)
- SUBMITTED TO: (Filed With SEC on September 18, 2006)
- PROPOSAL FOR: Stability Program for Difluprednate Ophtahlmic Solution for Sirion Therapeutics (Filed With SEC on September 18, 2006)